These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

306 related articles for article (PubMed ID: 21414418)

  • 1. Learning lessons from drugs that have recently entered the market.
    Teague SJ
    Drug Discov Today; 2011 May; 16(9-10):398-411. PubMed ID: 21414418
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Improving drug candidates by design: a focus on physicochemical properties as a means of improving compound disposition and safety.
    Meanwell NA
    Chem Res Toxicol; 2011 Sep; 24(9):1420-56. PubMed ID: 21790149
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Wrong questions, wrong answers? Are we getting the drugs we need?
    Lipworth WL; Kerridge IH; Day RO
    Clin Pharmacol Ther; 2012 Mar; 91(3):367-9. PubMed ID: 22343808
    [No Abstract]   [Full Text] [Related]  

  • 4. Synthetic therapeutic peptides: science and market.
    Vlieghe P; Lisowski V; Martinez J; Khrestchatisky M
    Drug Discov Today; 2010 Jan; 15(1-2):40-56. PubMed ID: 19879957
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Portfolio management in early stage drug discovery - a traveler's guide through uncharted territory.
    Betz UA
    Drug Discov Today; 2011 Jul; 16(13-14):609-18. PubMed ID: 21600301
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Can biochemistry drive drug discovery beyond simple potency measurements?
    Chène P
    Drug Discov Today; 2012 Apr; 17(7-8):388-95. PubMed ID: 22326379
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proof of concept: a PhRMA position paper with recommendations for best practice.
    Cartwright ME; Cohen S; Fleishaker JC; Madani S; McLeod JF; Musser B; Williams SA
    Clin Pharmacol Ther; 2010 Mar; 87(3):278-85. PubMed ID: 20130568
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lessons learned from candidate drug attrition.
    Empfield JR; Leeson PD
    IDrugs; 2010 Dec; 13(12):869-73. PubMed ID: 21154145
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anticipating drug side effects by comparative pharmacology.
    Garcia-Serna R; Mestres J
    Expert Opin Drug Metab Toxicol; 2010 Oct; 6(10):1253-63. PubMed ID: 20662552
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The challenges of immunogenicity in developing biosimilar products.
    Wadhwa M; Thorpe R
    IDrugs; 2009 Jul; 12(7):440-4. PubMed ID: 19579165
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Follow-on drugs: how far should chemists look?
    Giordanetto F; Boström J; Tyrchan C
    Drug Discov Today; 2011 Aug; 16(15-16):722-32. PubMed ID: 21658467
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Network biology as a new approach to drug discovery.
    Lowe JA; Jones P; Wilson DM
    Curr Opin Drug Discov Devel; 2010 Sep; 13(5):524-6. PubMed ID: 20812143
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ADMET--Fifth Annual SMi Conference.
    Comer JE
    IDrugs; 2010 Sep; 13(9):610-4. PubMed ID: 20799141
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differences between Japan and the United States in dosages of drugs recently approved in Japan.
    Nakashima K; Narukawa M; Kanazu Y; Takeuchi M
    J Clin Pharmacol; 2011 Apr; 51(4):549-60. PubMed ID: 20628171
    [TBL] [Abstract][Full Text] [Related]  

  • 15. What makes a good drug target?
    Gashaw I; Ellinghaus P; Sommer A; Asadullah K
    Drug Discov Today; 2011 Dec; 16(23-24):1037-43. PubMed ID: 21945861
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Do technical and commercial biases contribute to the pharmaceutical industry's productivity problems? An analysis of how reordering priorities can improve productivity.
    Fryburg DA
    Drug Discov Today; 2010 Sep; 15(17-18):766-72. PubMed ID: 20599625
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The value of in silico chemistry in the safety assessment of chemicals in the consumer goods and pharmaceutical industries.
    Modi S; Hughes M; Garrow A; White A
    Drug Discov Today; 2012 Feb; 17(3-4):135-42. PubMed ID: 22063083
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Organizing for innovation: towards successful translational research.
    West W; Nightingale P
    Trends Biotechnol; 2009 Oct; 27(10):558-61. PubMed ID: 19683820
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Drug Discovery Portal: a resource to enhance drug discovery from academia.
    Clark RL; Johnston BF; Mackay SP; Breslin CJ; Robertson MN; Harvey AL
    Drug Discov Today; 2010 Aug; 15(15-16):679-83. PubMed ID: 20547242
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Where do innovative drugs come from?
    Higgs G
    Drug Discov Today; 2011 Nov; 16(21-22):907-9. PubMed ID: 21889605
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 16.